In support of this conclusion, BCI, a compound identified as an allosteric inhibitor of DUSP6/MKP-3, caused a rapid increase in ERK activity in patient-derived Ph+ ALL cells. This evidence concerns the gene DUSP6 and acute lymphoblastic leukemia.